Figure 1. Integrin ␣v␤3 and MMP-2 Colocalize on Angiogenic Blood Vessels
Basic fibroblast growth factor-stimulated CAMs from 13-day-old chick embryos and ␣v␤3-negative human melanoma tumors (M21-L) grown in human skin were resected and snap-frozen in liquid nitrogen. Cryostat sections (4 m) were costained with both MAb LM609 directed to integrin ␣v␤3 and polyclonal antibodies directed to MMP-2. (A) Basic fibroblast growth factor-stimulated chick embryo angiogenic blood vessels. Arrows indicate quiescent blood vessels lacking expression of integrin ␣v␤3. (B) Human angiogenic blood vessels associated with a human melanoma tumor. Red indicates expression of integrin ␣v␤3, green indicates expression of MMP-2, and yellow indicates colocalization of integrin ␣v␤3 and MMP-2. Bar indicates 25 m.
critical role in this process (Moses et al., 1990 ; Moses severe combined immunodeficient mice. Tumors were propagated for 3 weeks, at which time they became and Langer, 1991). Therefore, we examined the localization of ␣v␤3 and the metalloproteinase MMP-2 on endohighly vascularized with human blood vessels, as previously described (Brooks et al., 1994b) . Once again, thelial cells undergoing angiogenesis. Basic fibroblast growth factor was used to induce angiogenesis on the ␣v␤3 and MMP-2 were colocalized on the angiogenic tumor-associated blood vessels ( Figure 1B ). Minimal chorioallantoic membranes (CAM) of 10-day-old chick embryos. The CAMs were resected and cryostat secstaining of ␣v␤3 or MMP-2 was detected in association with pre-existing nontumor-associated blood vessels tions were immunologically stained for the presence of ␣v␤3 and MMP-2, 3 days later. As shown in Figure 1A , (data not shown). Together, these findings suggest that integrin ␣v␤3 and MMP-2 associate on the same vascu␣v␤3 was highly expressed on angiogenic vessels, as previously described (Brooks et al., 1994a) . Interestlar sprouts during cytokine-induced angiogenesis on the chick CAM or tumor-induced angiogenesis within the ingly, MMP-2 was observed to colocalize with ␣v␤3 on the angiogenic vessels that expressed ␣v␤3 integrin but microenvironment of human skin. was only minimally expressed on vessels that lacked this receptor (Figure 1, arrows) .
Expression of ␣v␤3 on Melanoma Cells Promotes Angiogenesis is associated with the growth of all solid
Colocalization with MMP-2 In Vivo tumors. To determine whether ␣v␤3 and MMP-2 were
In addition to angiogenic vascular cells, certain invasive also colocalized on tumor-associated blood vessels, tumors express integrin ␣v␤3. In particular, human verti␣v␤3-negative M21-L human melanoma cells were injected into the dermis of human skin grafts grown on cally invasive primary and metastatic melanomas have Control CS-1 melanoma cells or CS-1 cells transfected with cDNAs encoding either ␤3 (␤3CS-1) or ␤5 (␤5CS-1) integrin subunit were inoculated on the CAMs of 10-day-old chick embryos. Tumors were allowed to grow for 7 days, then resected and snap-frozen in liquid nitrogen.
(A) Cryostat sections (4 m) from CS-1 tumor variants stained with a polyclonal antibody directed to MMP-2. Immunofluoresence was detected with an Olympus BX60 epifluoresence microscope at 400 ϫ.
(B) A single cryostat section from a ␤3CS-1 melanoma tumor was dual-stained with both MAb LM609 directed to integrin ␣v␤3 and polyclonal anti-MMP-2 antibody. Fluoresence was detected with a Zeiss-laser confocal microscope at 400 ϫ (200 nm Z-section). Red indicates expression of integrin ␣v␤3, and green indicates expression of MMP-2. Yellow indicates colocalization.
been shown to express ␣v␤3 preferentially, compared those transfected with cDNAs encoding either ␤3 or ␤5 integrin subunits were implanted on the CAMs of 10-with noninvasive primary melanomas (Albelda et al., 1990) . To evaluate a possible interaction between day-old chick embryos. As shown in Figure 2A , ␣v␤3-bearing tumors showed extensive staining with anti-MMP-2 and ␣v␤3 on melanoma cells, we examined CS-1 melanoma cells that failed to express either integrin MMP-2 (Figure 2 , left panel). In contrast, tumors derived from CS-1 cells lacking integrin ␣v␤3 or those express␣v␤3 or ␣v␤5 owing to the lack of ␤3 or ␤5 protein (Thomas et al., 1993; Filardo et al., 1995) . CS-1 cells or ing ␣v␤5 showed little, if any, detectable tumor cell-associated MMP-2, even though MMP-2 was readily detected within the stroma of all tumors examined (middle and right panels). The surface-associated MMP-2 present on ␤3CS-1 tumors showed extensive colocalization with integrin ␣v␤3, as measured by confocal analysis ( Figure 2B ). These observations suggest that MMP-2 selectively associates with ␣v␤3-bearing melanoma cells in vivo. Interestingly, while ␣v␤3 was detected both within and on the surface of these ␤3CS-1 tumor cells, MMP-2 appeared to associate exclusively with the cell surface of ␣v␤3-bearing cells, since it was not detected within the cytoplasm of these cells as measured by confocal analysis ( Figure 2B ). This is likely due to the failure of these cells to produce significant quantities of endogenous MMP-2 (Thomas et al., 1993) . These observations suggest that the increased association of MMP-2 on ␣v␤3-bearing cells is due to the ability of these proteins to interact on the cell surface and that the source of MMP-2 present on these tumors is host-derived.
MMP-2 Associated with ␣v␤3 on CS-1 Cells Is Functionally Active
To establish whether the MMP-2 associated with these tumors was in a functionally active form, lysates were prepared from ␤3CS-1, ␤5CS-1, or control CS-1 tumors. These lysates were then analyzed for MMP-2 activity by gelatin zymography. MMP-2 in the pro-enzyme form is 72 kDa; however, after proteolytic activation it appears as 64/62 kDa species (Kleiner et al., 1993) . As shown in Figure 3A , gelatinolytic bands from ␣v␤3-expressing tumor lysates were detected migrating at approximately 62 kDa. This activity was 3-fold higher than the gelatino- Lysates prepared from CS-1 solid tumor variants grown on the CAM determined by densitometry. These 62 kDa gelatinolytic of 10-day-old chick embryo were analyzed both by gelatin zymograbands were confirmed to be MMP-2 by Western blot phy (A) and Western blotting using anti-MMP-2 as a primary antibody (B). Lane 1, control purified recombinant chick MMP-2. Lane analysis ( Figure 3B ). In contrast, no significant changes 2, lysate (10 g) from ␤3CS-1 tumors. Lane 3, lysate (10 g) from were detected in uPA levels among these same tumors control CS-1 tumors. Lane 4, lysate (10 g) from ␤5CS-1 tumors.
(data not shown). Thus, CS-1 tumors expressing integrin ␣v␤3 had significantly enhanced levels of proteolytically expressing ␣v␤3 were allowed to incubate with either active MMP-2 compared with tumors expressing intewild type (MMP-2 wild type) or a truncation mutant of grin ␣v␤5 or controls.
MMP-2 (⌬MMP-2 (1-445)) lacking residues 446-631. This These findings raise the possibility that ␣v␤3 ligation truncated form of MMP-2 retains a functional catalytic on CS-1 cells leads to the induction of MMP-2 expresdomain with gelatinolytic activity equal to that of the sion in these tumors, which may account for the inwild-type enzyme (data not shown). Binding of MMP-2 to creased MMP-2 activity observed. However, ligation of ␣v␤3 was monitored by an anti-␤3 monoclonal antibody ␣v␤3 does not appear to promote expression of gela-(MAb) directed to the ligand occupied form of ␣v␤3, tinolytic activity in ␤3CS-1 cells, since attachment of termed Ligand-Induced Binding Site 1 (LIBS-1). This anthese cells to vitronectin, fibronectin, or collagen failed tibody detects the ligand-occupied forms of both ␣IIb␤3 to increase gelatinolytic activity compared with nonon platelets (Frelinger et al., 1990 ) and ␣v␤3 on melaattached cells (data not shown). These findings provide noma cells (Filardo et al., 1995) . As shown in Figure 4 , further evidence that the MMP-2 observed within these MMP-2 (wild type) but not ⌬MMP-2 (1-445) promoted tumors is likely derived from host tissues.
LIBS-1 binding activity, as measured by flow cytometric analysis. This LIBS-1 binding was similar to that observed when ␣v␤3 was occupied with soluble vitronectin Interaction of Soluble MMP-2 with Integrin or cyclic RGDfV peptide (Figure 4 ). These findings sug␣v␤3 on the Cell Surface gest that soluble MMP-2 can interact with integrin ␣v␤3 To establish whether soluble MMP-2 can specifically expressed on the cell surface and that this interaction depends on the presence of its C-terminus. bind ␣v␤3 expressed on the cell surface, CS-1 cells 
Soluble MMP-2 Selectively Prevents Adhesion of ␣v␤3-Bearing CS-1 Cells to Vitronectin
To explore further the interaction between MMP-2 and cell-surface ␣v␤3, ␤3CS-1 cells were allowed to attach to vitronectin or laminin in the presence of excess soluble MMP-2 (wild type) or ⌬MMP-2(1-445). As shown in Figure 5 , soluble MMP-2 blocked cell adhesion to vitronectin but had no effect on adhesion to laminin. Similar results were obtained with a cyclic peptide antagonist of ␣v␤3 (RGDfV), which selectively blocked adhesion to vitronectin while a control cyclic peptide (RADfV) had no effect. We then examined the effects of ⌬MMP-2 (1-445) . Once again, this truncation mutant did not appear to interact with ␣v␤3, since it was unable to block vitronectin-mediated attachment of these cells. These findings support the notion that ␣v␤3-expressing CS-1 cells can interact with MMP-2 in a manner that depends on a region within the C-terminal 181 amino acid residues of MMP-2.
MMP-2 Binds Specifically to Purified Integrin ␣v␤3 Forming an SDS-Stable Complex
To establish whether MMP-2 could directly bind ␣v␤3, we first examined the ability of recombinant MMP-2 to interact with purified ␣v␤3 in a solid-phase binding assay. Integrins ␣v␤3, ␣v␤5, or the fibronectin receptor ␣5␤1 were coated onto microtiter wells and allowed to interact with either MMP-2, vitronectin, fibronectin, or collagen, as previously described (Orlando and Cher- control cyclic peptide 601 (RADfV) (data not shown).
These findings demonstrate that MMP-2 specifically binds integrin ␣v␤3 while having a minimal interaction with ␣v␤5 and showing no binding to the fibronectin receptor, ␣5␤1.
To examine further the interaction between integrin ␣v␤3 and MMP-2, these proteins were allowed to interact in solution and were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) without boiling. As shown in Figure 6C , addition of MMP-2 to purified ␣v␤3 resulted in the formation of SDS-stable complexes, as demonstrated by the presence of slowly migrating broad bands (approximately 200 kDa and 150 kDa) and the concomitant dose-dependent decrease of the ␣v and ␤3 integrin subunits. In contrast, no complex formation was detected between MMP-2 and ␣5␤1. In addition, the truncation mutant also failed to form a complex with ␣v␤3 ( Figure 6C ). Boiling these samples prior to their separation by SDS-PAGE resulted in the dissociation of the complexes such that the ␣v and ␤3 subunits migrated in their normal positions of 145 kDa and 95 kDa, respectively (data not shown). To establish that the shifted bands contained either ␣v or ␤3 integrin subunits, we analyzed these same samples by Western blot with antibodies directed either to ␣v or ␤3 ( Figure  6D ). As shown in Figure 6D (left panel), anti-␤3 antibody readily detects the ␤3 subunit of purified ␣v␤3 as well as the lower of the two shifted bands, with an apparent molecular mass of approximately 150 kDa. Likewise, anti-␣v antibody recognized both the ␣v subunit from purified ␣v␤3 and the broad shifted band migrating at approximately 200 kDa. Taken together, these data demonstrate that the full-length MMP-2 is capable of forming an SDS-stable complex with integrin ␣v␤3, providing further evidence that these proteins physically interact.
MMP-2 on the Surface of ␣v␤3-Expressing Cells Is Functionally Active
To determine whether the MMP-2 localized on the surface of ␣v␤3-expressing CS-1 cells was functionally active, we incubated CS-1 cells expressing ␣v␤3, ␣v␤5, or control CS-1 cells with MMP-2 and then added to (A) Purified integrin receptors (1 g/ml), ␣v␤3, ␣v␤5, and ␣5␤1 were coated on wells of a 96-well microtiter plate. Integrin ligands, including vitronectin, collagen, and fibronectin or purified recombinant MMP-2 (5 ng), were incubated in wells coated with integrin receptors. Specific protein binding was quantified by measuring reactivity of ligand-specific antibodies. Data bars represent the mean plus or minus standard errors of ligand binding from three to five experiments with triplicate wells. (B) Microtiter plates were coated with purified integrin ␣v␤3. Integrin ligands, including vitronectin and collagen or recombinant MMP-2, at concentrations ranging from 5 ng/ml-500 ng/ml, were allowed to bind to integrin-coated wells. Dose response binding was quantified as described above. (C) Purified integrins ␣v␤3 and ␣5␤1 were incubated with soluble wild-type MMP-2 (wt) (5 ng-40 ng/lane) or C-terminal mutant MMP-2 (1-445) (20 ng/lane) for 4 hr at 37ЊC in a total volume of 100 l. Samples were analyzed by silver stain on a 6% SDS-PAGE gel without boiling. (D) Purified ␣v␤3 or ␣v␤3 incubated with MMP-2 as described above were analyzed by Western blotting with antibodies directed either to the ␤3 integrin subunit (left panel) or the ␣v integrin subunit (right panel).
and Zetter, 1990; Albelda, 1993) . This process depends both on adhesion and migration and on proteolytic mechanisms that function in a coordinated manner to provide directional cell migration (Albelda, 1993; Blasi, 1993; Mignatti and Rifkin, 1993) . Thus, adhesion receptors that potentiate cell invasion must function in the context of specific proteases that serve to modify components within the extracellular matrix. To this end, evidence is provided that integrin ␣v␤3 not only promotes cell migration on a wide range of matrix proteins (Felding-Habermann and Cheresh, 1993) but also serves as a receptor for MMP-2 on the cell surface, facilitating its expression in a functionally active form. These findings provide unique evidence for a single cell-surface receptor capable of regulating both cell movement and proteolytic degradation of matrix.
Several lines of evidence suggest that integrin ␣v␤3 binds MMP-2 and acts as a receptor for surface-localized metalloproteinase activity. First, ␣v␤3 and MMP-2 were colocalized on the surface of invasive angiogenic vascular cells and melanoma cells in vivo. Second, expression of ␣v␤3 on cultured CS-1 melanoma cells enabled them to bind soluble recombinant MMP-2, facilitating collagen degradation. In addition, MMP-2 inhibited ␤3CS-1 cell attachment to vitronectin. However, these cells could attach and spread on immobilized type IV collagen in the presence of active cell surfaceassociated MMP-2 (data not shown). These findings interaction between ␣v␤3 and MMP-2 was demon-(␤3CS-1) or ␣v␤5 (␤5CS-1) were incubated with or without purified recombinant MMP-2, and nonbound enzyme was washed free. CSstrated between these proteins in vitro. In fact, they 1 cell variants were incubated for 24 hr in wells of a microtiter plate formed an SDS-stable complex that depended on the that MMP-2 does not contain an RGD sequence and, thus, it is not clear how ␣v␤3 interacts with MMP-2. However, removal of 181 residues from the C-terminus microtiter wells coated with 3 H-labeled type IV collagen. abolishes this binding event, suggesting that the C-ter-MMP-2 activity was monitored by collagen IV degradaminus of MMP-2 is required for this interaction. These tion, as measured by release of cpm into the medium.
findings are consistent with a role for the C-terminus of As shown in Figure 7A , only ␣v␤3-expressing CS-1 cells MMP-2 in its localization to the cell surface (Strongin et caused a significant increase in collagen degradation, al., 1995; Cao et al., 1995) . Moreover, this truncated form as compared with either control or ␣v␤5-expressing of MMP-2 still retains its catalytic activity, suggesting CS-1 cells. In contrast, when ␣v␤3-bearing CS-1 cells that cell-surface binding and enzymatic activities are were preincubated with the C-terminal truncated form represented by distinct domains of this enzyme. of MMP-2, which retains its collagenolytic activity, no
Our findings are consistent with previous reports significant increase in type IV collagen degradation was showing that MMP-2 as well as integrin receptors localdetected ( Figure 7B ). This cell-surface collagenolytic acize to the invadopodia of Rous sarcoma virus-transformed tivity was sensitive to the metalloproteinase inhibitor chick embryo fibroblast (Monsky et al., 1993; Mueller 1-10 phenanthroline and was insensitive to the serine and . Interestingly, this localization was deproteinase inhibitor aprotinin (data not shown), sugpendent on the presence of Ca 2ϩ and Mg 2ϩ (Monsky et gesting that the MMP-2 added to these cells, which al., 1993), which are also critical for integrin function. bound to ␣v␤3, was responsible for the observed collaTo date, little is known regarding the biochemical intergen degradation.
actions between MMPs and the cell surface. However, a transmembrane form of MMP was recently identified Discussion called MT-MMP . This novel metalloproteinase, in conjunction with tissue inhibitor of metalDirected cell motility in tissues is critical during developloproteinase-2 (TIMP-2), has been implicated in localization and activation of MMP-2 on the cell surface ment, wound repair, inflammation, and cancer (Blood Experimental Procedures (Strongin et al., 1995) . However, it is not clear how this trimolecular interaction might potentiate the migration Antibodies and Reagents of cells in vivo. In addition, the serine proteinase uPA MAb LIBS-1, which reacts preferentially with the ligand-occupied binds to its receptor, termed uPAR, which associates form of ␤3 integrins (Frelinger et al., 1990 ) was provided by Dr.
with the outer leaflet of the bilayer (Blasi, 1993) . This M. Ginsberg (Scripps Research Institute, La Jolla, CA). MAb and uPA enzymatic activity appears to potentiate tumor cell polyclonal antisera to human progelatinase A (MMP-2) was recently invasive behavior (Crowley et al., 1993; Kook et al., described (Brown et al., 1990) . Polyclonal antibody to fibronectin 1994). In fact, recent evidence suggests that proteases was obtained from Chemicon (Temecula, CA). MAb LM609, antiand their receptors may be functionally associated with ␣v␤3, and polyclonal antibodies 661 to vitronectin have been described previously (Gladson and Cheresh, 1991; Wayner et al., 1991). integrin receptors. For example, it has been shown that MAb AP3 (Newman et al., 1985) was provided by Dr. P. Newman uPAR colocalizes with integrin ␣v␤5 on migratory cells (Milwaukee Blood Center, Milwaukee, WI) . Polyclonal antibodies to (Reinartz et al., 1995) . However, no biochemical evitype I collagen and ␣v integrin subunit were obtained from Chemidence exists suggesting that these receptors are struc- contains both integrin binding sequences and a metalloArgraves (American Red Cross, Washington, DC). Integrins ␣v␤3 and ␣v␤5 were purified from placental tissues as previously described proteinase catalytic domain (Wolfsberg et al., 1993 Smith and Cheresh, 1988) . Recombinant chick 1995), suggesting the possibility of integrin-mediated MMP-2 and C-terminal truncation mutant ⌬MMP-2 (1-445) was concell-surface localization of metalloproteinase activity. structed as previously described (Aimes et al., 1994) .
H-labeled
The finding that ␣v␤3 binds MMP-2 on the cell surface type IV collagen (1.075 mCi/mg) was obtained from Dupont NEM suggests that this interaction may contribute to cellular (Boston, MA) . Purified laminin and fibronectin were obtained from invasion in vivo. In support of this contention is the Sigma (St. Louis, MO). Collagen type I was obtained from UBI (Lake observation that ␣v␤3 and MMP-2 were colocalized on Placid, NY). Cyclic peptides 66203 (cyclo-RGDfV) directed to ␣v␤3 and ␣v␤5 and control peptide 69601 (cyclo-RADfV) (Pfaff et al., 1994;  the surface of both angiogenic vascular cells and inva- Friedlander et al., 1995) with proteolyzed collagen owing to exposure of a cryptic RGD site (Davis, 1992; Montgomery et al., 1994) , sug-
Cell Lines and Solid Tumors
gesting that ␣v␤3 on the surface of invasive cells can CS-1 hamster melanoma cells lacking expression of ␣v␤3 and ␣v␤5 both regulate collagen degradation and interact with the were provided by Dr. C. Damsky (University of California, San Franresulting fragments. In fact, this is supported by the cisco, CA) (Knudsen et al., 1982; Thomas et al., 1993) . CS-1 cells observation that ␣v␤3 antagonists (Brooks et al., 1994b, were transfected with either ␤3 (␤3CS-1) or ␤5 (␤5CS-1) integrin 1995), as well as tissue inhibitors of metalloproteinases, subunits as described previously (Filardo et al., 1995 (Filardo et al., , 1996 . CS-1 tumor cell variants were maintained in RPMI 1640 with 5% fetal block angiogenesis in vivo (Moses et al., 1990) . Thus, it bovine serum supplemented with 50 g/ml gentamicin. Solid melais possible that ␣v␤3 and MMP-2 functionally cooperate noma tumors were produced by inoculating the CAMs of 10-dayto promote the invasive behavior of angiogenic vascular old chick embryos with 5 ϫ 10 6 CS-1, ␤3CS-1, or ␤5CS-1 tumor cells. Likewise, highly invasive melanoma cells typically cells, as previously described (Brooks et al., 1993; invade vertically into the dermis, which is rich in collagen 1995). The tumors were allowed to develop for 7 days, then trimmed (Albelda et al., 1990) . In fact, we observed that melanoma free of surrounding CAM tissue and minced for lysate preparation.
cells expressing ␣v␤3 were highly invasive in vivo comFor analysis of angiogenic blood vessels, the CAMs of 10-dayold chick embryo were treated with or without basic fibroblast pared with cells lacking this integrin (Filardo et al., 1995) . growth factor as previously described (Brooks et al., 1994a) . The
It is conceivable that this difference in invasive behavior
CAMs were resected, washed in phosphate-buffered saline (PBS), in vivo is due in part to the ability of ␣v␤3 to bind to (Figure 2 ) while ␣v␤3 was detected both on severe combined immunodeficient mice, as previously described (Yan et al., 1993; on the surface and within the cytoplasm of ␤3CS-1 tumor cells. In addition, CS-1 cells produce little if any gelatinolytic activity in vitro (Thomas et al., 1993) , and attachGelatin Zymography and Western Blot Analysis Cultured CS-1 tumor cells or fragments of solid CS-1 tumors grown ment of ␣v␤3-expressing CS-1 cells to vitronectin does in vivo were finely minced and resuspended in lysis buffer containing not increase MMP-2 expression, suggesting that ligation 1% triton X-100, 50 mM Tris, 300 mM NaCl. Lysates were incubated of this receptor does not influence MMP-2 levels in these on ice for 15 min with occasional vortexing, and insoluble material tumor cells. Together, these results suggest that the was removed by centrifugation. Gelatin zymography was performed MMP-2 found to be associated with ␣v␤3-bearing as previously described (Nakajima et al., 1995) . Briefly, 10-20 g CS-1 cells is derived from the host tissues.
of total protein from lysates were electrophoresed through a 10%
The findings presented in this report demonstrate a SDS-PAGE gel polymerized with 0.2% gelatin. Gels were washed three times for 1 hr each in 2.5% triton X-100 to remove SDS.
novel interaction between an integrin and a protease on Gels were next incubated for 16 hr at 37ЊC in collagenase buffer the surface of invasive cells. The fact that ␣v␤3 promotes containing 50 mM Tris-HCL, 200 mM NaCl, and 10 mM CaCl 2 (pH cell motility while MMP-2 potentiates matrix degradation 7.5). Gelatinolytic activity was visualized by staining the gels with suggests that these proteins function in a cooperative 0.5% Coomassie blue. To detect plasminogen activators, plasminomanner to promote the invasive behavior of cells during gen (1.2 mg/ml) was copolymerized with the gels and collagenase tissue remodeling, inflammation, development, and inhibitors EDTA (20 mM), and 1-10 phenathroline (1 mM) was added to the gel incubation buffer. For Western blot analysis, 10 g of cancer.
tumor lysates or equal volumes of ␣v␤3/MMP-2 complex were elecfor 30 min at 37ЊC. CS-1 tumor cells (1 ϫ 10 5 ) resuspended in adhesion buffer, fibroblast basal medium containing 0.5% BSA, and 0.2 trophoresed on a 6% SDS-PAGE gel under nonreducing conditions. Proteins were transferred to nitrocellulose membranes and probed mM MnCl 2 were allowed to attach for 15 min. Plates were washed with adhesion buffer to remove nonattached cells, and attached with polyclonal anti-MMP-2 antibodies (1:1000), anti-␣v antibodies (1:500), or MAb AP3 (anti-␤3) (5 g/ml), followed by incubation with cells were stained with 1% crystal violet. Cell-associated crystal violet was eluted by the addition of 100 l of 10% acetic acid. Cell peroxidase-labeled secondary antibodies. Western blots were visualized by enhanced chemiluminescence detection system acadhesion was quantified by measuring the optical density of the eluted crystal violet at a wavelength of 600 nm. cording to the manufacturer's instructions. MMP-2 activity was quantified by densitometric scanning of zymographic bands.
Flow Cytometry Immunofluoresence Analysis of CS-1 Melanoma Tumors
Fluorescence-activated cell sorting was performed as previously Immunofluorescent staining was performed as previously dedescribed (Brooks et al., 1994b) . Briefly, subconfluent ␤3CS-1 cells scribed, with minor modifications . Micron cryowere harvested with versene and washed three times with serumstat sections (4) of ␤3CS-1, ␤5CS-1, and control CS-1 tumors were free RPMI 1640. Cells were incubated for 30 min with peptides 69601 incubated with 1% bovine serum albumin (BSA) in PBS for 1 hr at (RADfV), 66203 (RGDfV) (100 M), vitronectin, BSA (100 M), room temperature, followed by incubation with polyclonal anti-MMP-2, or ⌬MMP-2(1-445) (4 nM). Cells were incubated with MAb MMP-2 antisera at a dilution of 1:250 in 1% BSA in PBS for 2 hr.
LIBS-1 (15 g/ml) in 0.5% BSA in fibroblast basal medium suppleTissue sections were washed five times with PBS for 5 min, followed mented with 0.2 mM MnCl2, washed two times and incubated with by incubation with FITC conjugated goat anti-rabbit IgG. Tissue phycoerythrin-labeled goat anti-mouse IgG at a dilution of 1:50. The sections were washed as described above and mounted with fluorocells were then analyzed by fluorescence-activated cell sorting. Cell mount G (Southern Biotechnology Associates, Birmingham, AL). For fluorescence was measured with a FACScan flow cytometer (Becdouble-staining analysis, anti-␣v␤3 MAb LM609 (30g/ml) and polyton-Dickinson, Mountain View, CA). The data were collected with a clonal anti-MMP-2 (1:250) were incubated together for 2 hr at room Hewlett-Packard (HP9000) computer equipped with FACScan retemperature. After washing, tissue sections were incubated with search software. The data was analyzed with PC Lysis software. both rhodamine-conjugated goat anti-mouse IgG and FITC conjuPopulation gates were set using cells incubated without primary gated goat anti-rabbit IgG at a dilution of 1:250 in 1% BSA in PBS.
antibody. LIBS-1 binding was corrected by subtracting binding from cells in the absence of ligand.
Solid-Phase Binding Assay
Purified receptor binding assays were performed essentially as de-3 H-Labeled Type IV Collagen Degradation Assay scribed, with minor modifications .
Cluster plates (96-well) were coated with 50 l of 3 H-labeled type Briefly, enzyme-linked immunoabsorbent assay plates were coated IV collagen solution (500-1000 cpm/g protein) and allowed to dry (100 l) with 1.0 g/ml of purified integrins ␣v␤3, ␣v␤5, or ␣5␤1 in overnight in a laminar flow hood at room temperature. Plates were binding buffer containing 20 mM Tris, 150 mM NaCl, and 1 mM washed extensively with PBS until free cpm reached basal levels. CaCl 2, MgCl2, and MnCl2 (pH 7.4) for 16 hr at 4ЊC. The plates were CS-1 tumor cells were incubated for 2 hr in the presence or absence washed three times with 200 l/well of sterile PBS. Plates were then of purified MMP-2 or C-terminal-truncated MMP-2 (200 ng/ml) in a incubated (100 l) with 0.5% protease-free BSA in PBS for 1 hr at total volume of 500 l of fibroblast basal medium containing 2.5% 37ЊC and then washed six times with sterile PBS (200 l/well). Puri-BSA, 0.2 mM MnCl2 and 10 g/ml aprotinin. In control experiments, fied ligands including vitronectin, collagen type I, fibronectin, and 1 mM 1-10 phenanthroline was added to the buffer. CS-1 tumor MMP-2 (0.5-50 ng/well) in a total volume of 100 l were incubated cells (1 ϫ 10 5 ) in a total volume of 200 l were allowed to incubate for 1 hr at 37ЊC. Plates were washed as before, followed by incubafor 24 hr at 37ЊC. Collagen degradation was accessed by measuring tion with anti-ligand specific polyclonal antisera at a dilution ranging the cpm released in 50 l of medium. Net collagen IV degradation from 1:1000 to 1:5000 in 0.5% BSA in PBS for 1 hr at 37ЊC. The was determined by subtracting cpm released in the absence of enzyme-linked immunoabsorbent assay plates were washed as beadded MMP-2. fore and incubated with peroxidase-conjugated goat anti-rabbit IgG at a dilution of 1:3000 in 0.5% BSA in PBS. Finally, plates were Acknowledgments washed and developed by the addition of OPD (0.4 mg/ml) in 80 mM citrate-phosphate buffer (pH 5.0). Color reaction was stopped Correspondence should be addressed to D. A. C. The authors would by the addition of 25 l of 4N H 2S04. Plates were read at a wavelength like to thank Catherine Andrews for her expert technical assistance of 490 nm on an enzyme-linked immunoabsorbent assay plate and George Klier for his expert assistance with the confocal image reader. Optical density values were corrected for nonspecific ligand analysis. D. A. C. was supported by grants HL-54444, CA-50286, binding to BSA.
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